|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Kong J, Ha D, Lee J, Kim I, Park M, Im SH,
Shin K and Kim S: Network-based machine learning approach to
predict immunotherapy response in cancer patients. Nat Commun.
13:37032022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta A, Andresen JL, Manan RS and Langer
R: Nucleic acid delivery for therapeutic applications. Adv Drug
Deliv Rev. 178:1138342021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Webb K, Sharpe L, Butow P, Dhillon H,
Zachariae R, Tauber NM, O'Toole MS and Shaw J: Caregiver fear of
cancer recurrence: A systematic review and meta-analysis of
quantitative studies. Psychooncology. 32:1173–1191. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Potter AL, Costantino CL, Suliman RA,
Haridas CS, Senthil P, Kumar A, Mayne NR, Panda N, Martin LW and
Yang CJ: Recurrence after complete resection for non-small cell
lung cancer in the national lung screening trial. Ann Thorac Surg.
116:684–692. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gul S, Pang J, Yuan H, Chen Y, Yu Q, Wang
H and Tang W: Stemness signature and targeted therapeutic drugs
identification for Triple negative breast cancer. Sci Data.
10:8152023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haeckel E: Natürliche
schöpfungsgeschichte. Reimer Berlin. 1870.
|
|
8
|
Laplane L and Solary E: Towards a
classification of stem cells. Elife. 8:e465632019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramalho-Santos M and Willenbring H: On the
origin of the term ‘stem cell’. Cell Stem Cell. 1:35–38. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomasetti C and Vogelstein B: Cancer
etiology. Variation in cancer risk among tissues can be explained
by the number of stem cell divisions. Science. 347:78–81. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dentro SC, Leshchiner I, Haase K,
Tarabichi M, Wintersinger J, Deshwar AG, Yu K, Rubanova Y,
Macintyre G, Demeulemeester J, et al: Characterizing genetic
intra-tumor heterogeneity across 2,658 human cancer genomes. Cell.
184:2239–2254. e392021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng H, Pomyen Y, Hernandez MO, Li C,
Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, et al:
Single-cell analysis reveals cancer stem cell heterogeneity in
hepatocellular carcinoma. Hepatology. 68:127–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Waclaw B, Bozic I, Pittman ME, Hruban RH,
Vogelstein B and Nowak MA: A spatial model predicts that dispersal
and cell turnover limit intratumour heterogeneity. Nature.
525:261–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dirkse A, Golebiewska A, Buder T, Nazarov
PV, Muller A, Poovathingal S, Brons NHC, Leite S, Sauvageot N,
Sarkisjan D, et al: Stem cell-associated heterogeneity in
Glioblastoma results from intrinsic tumor plasticity shaped by the
microenvironment. Nat Commun. 10:17872019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osisami M and Keller ET: Mechanisms of
metastatic tumor dormancy. J Clin Med. 2:136–150. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Chen S, Zhuo L, Zhu Y and Zheng H:
Regulation of cancer stem cell properties, angiogenesis, and
vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
Cell Death Dis. 11:1732020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tape CJ: Plastic persisters: Revival stem
cells in colorectal cancer. Trends Cancer. 10:185–195. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fekir K, Dubois-Pot-Schneider H, Desert R,
Daniel Y, Glaise D, Rauch C, Morel F, Fromenty B, Musso O, Cabillic
F and Corlu A: Retrodifferentiation of human tumor hepatocytes to
stem cells leads to metabolic reprogramming and chemoresistance.
Cancer Res. 79:1869–1883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O'Connor SA, Feldman HM, Arora S,
Hoellerbauer P, Toledo CM, Corrin P, Carter L, Kufeld M, Bolouri H,
Basom R, et al: Neural G0: A quiescent-like state found in
neuroepithelial-derived cells and glioma. Mol Syst Biol.
17:e95222021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schwitalla S, Fingerle AA, Cammareri P,
Nebelsiek T, Goktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ,
Moreaux G, et al: Intestinal tumorigenesis initiated by
dedifferentiation and acquisition of stem-cell-like properties.
Cell. 152:25–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Plaks V, Kong N and Werb Z: The cancer
stem cell niche: How essential is the niche in regulating stemness
of tumor cells? Cell Stem Cell. 16:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Talukdar S, Bhoopathi P, Emdad L, Das S,
Sarkar D and Fisher PB: Dormancy and cancer stem cells: An enigma
for cancer therapeutic targeting. Adv Cancer Res. 141:43–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fane ME, Chhabra Y, Alicea GM, Maranto DA,
Douglass SM, Webster MR, Rebecca VW, Marino GE, Almeida F, Ecker
BL, et al: Stromal changes in the aged lung induce an emergence
from melanoma dormancy. Nature. 606:396–405. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gerstberger S, Jiang Q and Ganesh K:
Metastasis. Cell. 186:1564–1579. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu M, Zhang X, Zhang W, Chiou YS, Qian W,
Liu X, Zhang M, Yan H, Li S, Li T, et al: Cancer stem cell
regulated phenotypic plasticity protects metastasized cancer cells
from ferroptosis. Nat Commun. 13:13712022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laothamatas I, Rasmussen ES, Green CB and
Takahashi JS: Metabolic and chemical architecture of the mammalian
circadian clock. Cell Chem Biol. 30:1033–1052. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chun SK, Fortin BM, Fellows RC, Habowski
AN, Verlande A, Song WA, Mahieu AL, Lefebvre AEYT, Sterrenberg JN,
Velez LM, et al: Disruption of the circadian clock drives Apc loss
of heterozygosity to accelerate colorectal cancer. Sci Adv.
8:eabo23892022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Papagiannakopoulos T, Bauer MR, Davidson
SM, Heimann M, Subbaraj L, Bhutkar A, Bartlebaugh J, Vander Heiden
MG and Jacks T: Circadian Rhythm Disruption Promotes Lung
Tumorigenesis. Cell Metab. 24:324–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chan P, Nagai Y, Wu Q, Hovsepyan A,
Mkhitaryan S, Wang J, Karapetyan G, Kamenecka T, Solt LA, Cope J,
et al: Advancing clinical response against glioblastoma: evaluating
SHP1705 CRY2 activator efficacy in preclinical models and safety in
phase I trials. Neuro Oncol. 27:1772–1786. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu A, Wiesner S, Xiao J, Ericson K, Chen
W, Hall WA, Low WC and Ohlfest JR: Expression of MHC I and NK
ligands on human CD133+ glioma cells: Possible targets of
immunotherapy. J Neurooncol. 83:121–131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ferrari de Andrade L, Kumar S, Luoma AM,
Ito Y, Alves da Silva PH, Pan D, Pyrdol JW, Yoon CH and
Wucherpfennig KW: Inhibition of MICA and MICB Shedding Elicits
NK-cell-mediated immunity against tumors resistant to cytotoxic T
cells. Cancer Immunol Res. 8:769–780. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holzgruber J, Martins C, Kulcsar Z,
Duplaine A, Rasbach E, Migayron L, Singh P, Statham E, Landsberg J,
Boniface K, et al: Type I interferon signaling induces melanoma
cell-intrinsic PD-1 and its inhibition antagonizes immune
checkpoint blockade. Nat Commun. 15:71652024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Celià-Terrassa T, Liu DD, Choudhury A,
Hang X, Wei Y, Zamalloa J, Alfaro-Aco R, Chakrabarti R, Jiang YZ,
Koh BI, et al: Normal and cancerous mammary stem cells evade
interferon-induced constraint through the miR-199a-LCOR axis. Nat
Cell Biol. 19:711–723. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roulois D, Loo Yau H, Singhania R, Wang Y,
Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, et al:
DNA-Demethylating agents target colorectal cancer cells by inducing
viral mimicry by endogenous transcripts. Cell. 162:961–973. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scheller M, Ludwig AK, Göllner S, Rohde C,
Krämer S, Stäble S, Janssen M, Müller JA, He L, Bäumer N, et al:
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid
leukemia sensitize cells to azacytidine via viral mimicry response.
Nat Cancer. 2:527–544. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu JM, Xia W, Hsu YH, Chan LC, Yu WH, Cha
JH, Chen CT, Liao HW, Kuo CW, Khoo KH, et al: STT3-dependent PD-L1
accumulation on cancer stem cells promotes immune evasion. Nat
Commun. 9:19082018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo
Y, Ren D, Hua Y, Yu B, Zhou Y, et al: Mechanisms of vasculogenic
mimicry in hypoxic tumor microenvironments. Mol Cancer. 20:72021.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ricci-Vitiani L, Pallini R, Biffoni M,
Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G,
Larocca LM and De Maria R: Tumour vascularization via endothelial
differentiation of glioblastoma stem-like cells. Nature.
468:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Spinelli C, Adnani L, Meehan B, Montermini
L, Huang S, Kim M, Nishimura T, Croul SE, Nakano I, Riazalhosseini
Y and Rak J: Mesenchymal glioma stem cells trigger
vasectasia-distinct neovascularization process stimulated by
extracellular vesicles carrying EGFR. Nat Commun. 15:28652024.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lucero R, Zappulli V, Sammarco A, Murillo
OD, Cheah PS, Srinivasan S, Tai E, Ting DT, Wei Z, Roth ME, et al:
Glioma-Derived miRNA-Containing extracellular vesicles induce
angiogenesis by reprogramming brain endothelial cells. Cell Rep.
30:2065–2074.e4. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang S, Zhu N, Li HF, Gu J, Zhang CJ,
Liao DF and Qin L: The lipid rafts in cancer stem cell: A target to
eradicate cancer. Stem Cell Res Ther. 13:4322022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ehteram H, Aslanbeigi F, Ghoochani
Khorasani E, Tolouee M and Haddad Kashani H: Expression and
prognostic significance of stem cell marker CD133 in survival rate
of patients with colon cancer. Oncol Ther. 10:451–461. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yamada-Hunter SA, Theruvath J, McIntosh
BJ, Freitas KA, Lin F, Radosevich MT, Leruste A, Dhingra S,
Martinez-Velez N, Xu P, et al: Engineered CD47 protects T cells for
enhanced antitumour immunity. Nature. 630:457–465. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu S, Tan Y, Li F, Han Y, Zhang S and Lin
X: CD44: A cancer stem cell marker and therapeutic target in
leukemia treatment. Front Immunol. 15:13549922024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xiao D, Xiong M, Wang X, Lyu M, Sun H, Cui
Y, Chen C, Jiang Z and Sun F: Regulation of the function and
expression of EpCAM. Biomedicines. 12:11292024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cao HZ, Yang WT and Zheng PS: Cytotoxic
effect of disulfiram/copper on human cervical cancer cell lines and
LGR5-positive cancer stem-like cells. BMC Cancer. 22:5212022.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ferragut F, Vachetta VS, Troncoso MF,
Rabinovich GA and Elola MT: ALCAM/CD166: A pleiotropic mediator of
cell adhesion, stemness and cancer progression. Cytokine Growth
Factor Rev. 61:27–37. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Y, Yu H, Yu M, Liu H, Zhang B, Wang
Y, Zhao S and Xia Q: CD24 blockade as a novel strategy for cancer
treatment. Int Immunopharmacol. 121:1105572023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sałagacka-Kubiak A, Zawada D, Saed L,
Kordek R, Jeleń A and Balcerczak E: ABCG2 Gene and ABCG2 protein
expression in colorectal cancer-in silico and wet analysis. Int J
Mol Sci. 24:105392023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhao H, Jiang R, Zhang C, Feng Z and Wang
X: The regulatory role of cancer stem cell marker gene CXCR4 in the
growth and metastasis of gastric cancer. NPJ Precis Oncol.
7:862023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu C, Qiang J, Deng Q, Xia J, Deng L,
Zhou L, Wang D, He X, Liu Y, Zhao B, et al: ALDH1A1 activity in
tumor-initiating cells remodels myeloid-derived suppressor cells to
promote breast cancer progression. Cancer Res. 81:5919–5934. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mirzaei S, Paskeh MDA, Entezari M,
Mirmazloomi SR, Hassanpoor A, Aboutalebi M, Rezaei S, Hejazi ES,
Kakavand A, Heidari H, et al: SOX2 function in cancers: Association
with growth, invasion, stemness and therapy response. Biomed
Pharmacother. 156:1138602022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Duan R, Du W and Guo W: EZH2: A novel
target for cancer treatment. J Hematol Oncol. 13:1042020.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang
S, Wang J, Zhang Y, Zhu D and Li L: Notch signaling pathway in
cancer: From mechanistic insights to targeted therapies. Signal
Transduct Target Ther. 9:1282024. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
He Z, He J and Xie K: KLF4 transcription
factor in tumorigenesis. Cell Death Discov. 9:1182023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Schulz A, Meyer F, Dubrovska A and
Borgmann K: Cancer stem cells and radioresistance: DNA repair and
beyond. Cancers (Basel). 11:8622019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Park SY, Kim JH, Choi JH, Lee CJ, Lee WJ,
Park S, Park ZY, Baek JH and Nam JS: Lipid raft-disrupting
miltefosine preferentially induces the death of colorectal cancer
stem-like cells. Clin Transl Med. 11:e5522021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ye DM, Ye SC, Yu SQ, Shu FF, Xu SS, Chen
QQ, Wang YL, Tang ZT and Pan C: Drug-resistance reversal in
colorectal cancer cells by destruction of flotillins, the key lipid
rafts proteins. Neoplasma. 66:576–583. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Riitano G, Manganelli V, Capozzi A, Mattei
V, Recalchi S, Martellucci S, Longo A, Misasi R, Garofalo T and
Sorice M: LRP6 mediated signal transduction pathway triggered by
tissue plasminogen activator acts through lipid rafts in
neuroblastoma cells. J Cell Commun Signal. 14:315–323. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Qiu X, Luo J and Fang L: AIBP,
angiogenesis, hematopoiesis, and atherogenesis. Curr Atheroscler
Rep. 23:12020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Shi D, Lv X, Zhang Z, Yang X, Zhou Z,
Zhang L and Zhao Y: Smoothened oligomerization/higher order
clustering in lipid rafts is essential for high Hedgehog activity
transduction. J Biol Chem. 288:12605–12614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chung CL, Wang SW, Sun WC, Shu CW, Kao YC,
Shiao MS and Chen CL: Sorafenib suppresses TGF-β responses by
inducing caveolae/lipid raft-mediated internalization/degradation
of cell-surface type II TGF-β receptors: Implications in
development of effective adjunctive therapy for hepatocellular
carcinoma. Biochem Pharmacol. 154:39–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Du K, Li Y, Liu J, Chen W, Wei Z, Luo Y,
Liu H, Qi Y, Wang F and Sui J: A bispecific antibody targeting GPC3
and CD47 induced enhanced antitumor efficacy against dual
antigen-expressing HCC. Mol Ther. 29:1572–1584. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Abd El-Fattah EE and Selim HM:
Reprograming immune microenvironment modulates CD47 cancer stem
cells in hepatocellular carcinoma. Int Immunopharmacol. 113((Pt
B)): 1094752022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Chang CL, Wu CC, Hsu YT and Hsu YC: Immune
vulnerability of ovarian cancer stem-like cells due to low CD47
expression is protected by surrounding bulk tumor cells.
Oncoimmunology. 9:18035302020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liu X, Pu Y, Cron K, Deng L, Kline J,
Frazier WA, Xu H, Peng H, Fu YX and Xu MM: CD47 blockade triggers T
cell-mediated destruction of immunogenic tumors. Nat Med.
21:1209–1215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang JH, Huang ST, Zhang L, Liu ZG, Liang
RX, Jiang SW, Jiang YN, Yu XJ, Jiang YC, Li XZ, et al: Combined
prognostic value of the cancer stem cell markers CD47 and CD133 in
esophageal squamous cell carcinoma. Cancer Med. 8:1315–1325. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li Y, Liu J, Chen W, Wang W, Yang F, Liu
X, Sheng Y, Du K, He M, Lyu X, et al: A pH-dependent anti-CD47
antibody that selectively targets solid tumors and improves
therapeutic efficacy and safety. J Hematol Oncol. 16:22023.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Majeti R, Chao MP, Alizadeh AA, Pang WW,
Jaiswal S, Gibbs KD Jr, van Rooijen N and Weissman IL: CD47 is an
adverse prognostic factor and therapeutic antibody target on human
acute myeloid leukemia stem cells. Cell. 138:286–299. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Grabovenko FI, Kisil OV, Pavlova GV and
Zvereva ME: Protein CD133 as a tumor stem cell marker. Zh Vopr
Neirokhir Im N N Burdenko. 86:113–120. 2022.(In English, Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Peng H, Wu X, Liu S, He M, Xie C, Zhong R,
Liu J, Tang C, Li C, Xiong S, et al: Multiplex immunofluorescence
and single-cell transcriptomic profiling reveal the spatial cell
interaction networks in the non-small cell lung cancer
microenvironment. Clin Transl Med. 13:e11552023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
An HW, Seok SH, Kwon JW, Choudhury AD, Oh
JS, Voon DC, Kim DY and Park JW: The loss of epithelial Smad4
drives immune evasion via CXCL1 while displaying vulnerability to
combinatorial immunotherapy in gastric cancer. Cell Rep.
41:1118782022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Guan S, Yang R, Wu S, Xu K and Yang C: The
CD133(+)CXCR4(+) colorectal tumor cells promote colorectal cancer
progression by PI3K/AKT signaling. J Interferon Cytokine Res.
42:195–202. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wei Y, Jiang Y, Zou F, Liu Y, Wang S, Xu
N, Xu W, Cui C, Xing Y, Liu Y, et al: Activation of PI3K/Akt
pathway by CD133-p85 interaction promotes tumorigenic capacity of
glioma stem cells. Proc Natl Acad Sci USA. 110:6829–6834. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lu R, Zhao G, Yang Y, Jiang Z, Cai J and
Hu H: Inhibition of CD133 overcomes cisplatin resistance through
inhibiting PI3K/AKT/mTOR signaling pathway and autophagy in
CD133-positive gastric cancer cells. Technol Cancer Res Treat.
18:15330338198643112019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wu Z, Li W, Tang Q, Huang L, Zhan Z, Li Y,
Wang G, Dai X and Zhang Y: A novel aniline derivative from peganum
harmala L. Promoted apoptosis via activating PI3K/AKT/mTOR-mediated
autophagy in non-small cell lung cancer cells. Int J Mol Sci.
24:126262023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Matsumoto K, Arao T, Tanaka K, Kaneda H,
Kudo K, Fujita Y, Tamura D, Aomatsu K, Tamura T, Yamada Y, et al:
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133
expression in cancer cells. Cancer Res. 69:7160–7164. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Treffers LW, Ten Broeke T, Rösner T,
Jansen JHM, van Houdt M, Kahle S, Schornagel K, Verkuijlen PJJH,
Prins JM, Franke K, et al: IgA-mediated killing of tumor cells by
neutrophils is enhanced by CD47-SIRPα checkpoint inhibition. Cancer
Immunol Res. 8:120–130. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Qu T, Zhong T, Pang X, Huang Z, Jin C,
Wang ZM, Li B and Xia Y: Ligufalimab, a novel anti-CD47 antibody
with no hemagglutination demonstrates both monotherapy and combo
antitumor activity. J Immunother Cancer. 10:e0055172022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Shmelkov SV, Butler JM, Hooper AT, Hormigo
A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, et
al: CD133 expression is not restricted to stem cells, and both
CD133+ and CD133- metastatic colon cancer cells initiate tumors. J
Clin Invest. 118:2111–2120. 2008.PubMed/NCBI
|
|
82
|
Qin X, Cardoso Rodriguez F, Sufi J,
Vlckova P, Claus J and Tape CJ: An oncogenic phenoscape of colonic
stem cell polarization. Cell. 186:5554–5568.e18. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang
DW, Park JC, Il Kim T, Clevers H and Choi KY: 5-FU promotes
stemness of colorectal cancer via p53-mediated WNT/β-catenin
pathway activation. Nat Commun. 11:53212020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lee KM, Giltnane JM, Balko JM, Schwarz LJ,
Guerrero-Zotano AL, Hutchinson KE, Nixon MJ, Estrada MV, Sánchez V,
Sanders ME, et al: MYC and MCL1 cooperatively promote
chemotherapy-resistant breast cancer stem cells via regulation of
mitochondrial oxidative phosphorylation. Cell Metab. 26:633–647.e7.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Roos M, Pradère U, Ngondo RP, Behera A,
Allegrini S, Civenni G, Zagalak JA, Marchand JR, Menzi M, Towbin H,
et al: A small-molecule inhibitor of Lin28. ACS Chem Biol.
11:2773–2781. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Radaeva M, Ho CH, Xie N, Zhang S, Lee J,
Liu L, Lallous N, Cherkasov A and Dong X: Discovery of Novel Lin28
inhibitors to suppress cancer cell stemness. Cancers (Basel).
14:56872022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yang Y, Gomez N, Infarinato N, Adam RC,
Sribour M, Baek I, Laurin M and Fuchs E: The pioneer factor SOX9
competes for epigenetic factors to switch stem cell fates. Nat Cell
Biol. 25:1185–1195. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cheng Q, Zheng H, Li M, Wang H, Guo X,
Zheng Z, Chen C, Liu J, Zhan T, Li Z, et al: LGR4 cooperates with
PrPc to endow the stemness of colorectal cancer stem cells
contributing to tumorigenesis and liver metastasis. Cancer Lett.
540:2157252022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Dong J, Li J, Li Y, Ma Z, Yu Y and Wang
CY: Transcriptional super-enhancers control cancer stemness and
metastasis genes in squamous cell carcinoma. Nat Commun.
12:39742021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Bahr C, von Paleske L, Uslu VV, Remeseiro
S, Takayama N, Ng SW, Murison A, Langenfeld K, Petretich M,
Scognamiglio R, et al: A Myc enhancer cluster regulates normal and
leukaemic haematopoietic stem cell hierarchies. Nature.
553:515–520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Esposito F, Giuffrida R, Raciti G, Puglisi
C and Forte S: Wee1 kinase: A potential target to overcome tumor
resistance to therapy. Int J Mol Sci. 22:106892021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Terzo E, Apte SA, Padhye S, Rashed S,
Austin W, Caponegro M, Reddy A, Shi S, Wang C, Clark RB, et al: A
novel class of ribosome modulating agents exploits cancer ribosome
heterogeneity to selectively target the CMS2 subtype of colorectal
cancer. Cancer Res Commun. 3:969–979. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Karimi-Busheri F, Rasouli-Nia A, Mackey JR
and Weinfeld M: Senescence evasion by MCF-7 human breast
tumor-initiating cells. Breast Cancer Res. 12:R312010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Hembram KC, Dash SR, Das B, Sethy C,
Chatterjee S, Bindhani BK and Kundu CN: Quinacrine based gold
hybrid nanoparticles caused apoptosis through modulating
replication fork in oral cancer stem cells. Mol Pharm.
17:2463–2472. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Manic G, Signore M, Sistigu A, Russo G,
Corradi F, Siteni S, Musella M, Vitale S, De Angelis ML, Pallocca
M, et al: CHK1-targeted therapy to deplete DNA
replication-stressed, p53-deficient, hyperdiploid colorectal cancer
stem cells. Gut. 67:903–917. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zhao D, Mo Y, Li MT, Zou SW, Cheng ZL, Sun
YP, Xiong Y, Guan KL and Lei QY: NOTCH-induced aldehyde
dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
J Clin Invest. 124:5453–5465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ciccone V, Terzuoli E, Donnini S,
Giachetti A, Morbidelli L and Ziche M: Stemness marker ALDH1A1
promotes tumor angiogenesis via retinoic acid/HIF-1alpha/VEGF
signalling in MCF-7 breast cancer cells. J Exp Clin Cancer Res.
37:3112018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Rashid K, Ahmad A, Meerasa SS, Khan AQ, Wu
X, Liang L, Cui Y and Liu T: Cancer stem cell-derived
exosome-induced metastatic cancer: An orchestra within the tumor
microenvironment. Biochimie. 212:1–11. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Bilotta MT, Antignani A and Fitzgerald DJ:
Managing the TME to improve the efficacy of cancer therapy. Front
Immunol. 13:9549922022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Babaei G, Aziz SG and Jaghi NZZ: EMT,
cancer stem cells and autophagy; The three main axes of metastasis.
Biomed Pharmacother. 133:1109092021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Han Y, Villarreal-Ponce A, Gutierrez G Jr,
Nguyen Q, Sun P, Wu T, Sui B, Berx G, Brabletz T, Kessenbrock K, et
al: Coordinate control of basal epithelial cell fate and stem cell
maintenance by core EMT transcription factor Zeb1. Cell Rep.
38:1102402022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sadrkhanloo M, Entezari M, Orouei S,
Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H,
Hashemi M, et al: STAT3-EMT axis in tumors: Modulation of cancer
metastasis, stemness and therapy response. Pharmacol Res.
182:1063112022. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Lin LY, Du LM, Cao K, Huang Y, Yu PF,
Zhang LY, Li FY, Wang Y and Shi YF: Tumour cell-derived exosomes
endow mesenchymal stromal cells with tumour-promotion capabilities.
Oncogene. 35:6038–6042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Li H and Li F: Exosomes from BM-MSCs
increase the population of CSCs via transfer of miR-142-3p. Br J
Cancer. 119:744–755. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Valenti G, Quinn HM, Heynen GJJE, Lan L,
Holland JD, Vogel R, Wulf-Goldenberg A and Birchmeier W: Cancer
stem cells regulate cancer-associated fibroblasts via activation of
hedgehog signaling in mammary gland tumors. Cancer Res.
77:2134–2147. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kesh K, Gupta VK, Durden B, Garrido V,
Mateo-Victoriano B, Lavania SP and Banerjee S: Therapy resistance,
cancer stem cells and ECM in cancer: The matrix reloaded. Cancers
(Basel). 12:30672020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Sullivan WJ, Mullen PJ, Schmid EW, Flores
A, Momcilovic M, Sharpley MS, Jelinek D, Whiteley AE, Maxwell MB,
Wilde BR, et al: Extracellular matrix remodeling regulates glucose
metabolism through TXNIP destabilization. Cell. 175:117–132.
e212018. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Binnewies M, Roberts EW, Kersten K, Chan
V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI,
Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor
immune microenvironment (TIME) for effective therapy. Nat Med.
24:541–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zamarron BF and Chen W: Dual roles of
immune cells and their factors in cancer development and
progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J,
Li J, Li F and Tan HB: Immune cells within the tumor
microenvironment: Biological functions and roles in cancer
immunotherapy. Cancer Lett. 470:126–133. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Mellman I, Chen DS, Powles T and Turley
SJ: The cancer-immunity cycle: Indication, genotype, and
immunotype. Immunity. 56:2188–2205. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Lopez-Yrigoyen M, Cassetta L and Pollard
JW: Macrophage targeting in cancer. Ann N Y Acad Sci. 1499:18–41.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Allavena P, Digifico E and Belgiovine C:
Macrophages and cancer stem cells: A malevolent alliance. Mol Med.
27:1212021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Tao W, Chu C, Zhou W, Huang Z, Zhai K,
Fang X, Huang Q, Zhang A, Wang X, Yu X, et al: Dual role of WISP1
in maintaining glioma stem cells and tumor-supportive macrophages
in glioblastoma. Nat Commun. 11:30152020. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Raghavan S, Mehta P, Xie Y, Lei YL and
Mehta G: Ovarian cancer stem cells and macrophages reciprocally
interact through the WNT pathway to promote pro-tumoral and
malignant phenotypes in 3D engineered microenvironments. J
Immunother Cancer. 7:1902019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhou SL, Yin D, Hu ZQ, Luo CB, Zhou ZJ,
Xin HY, Yang XR, Shi YH, Wang Z, Huang XW, et al: A positive
feedback loop between cancer stem-like cells and tumor-associated
neutrophils controls hepatocellular carcinoma progression.
Hepatology. 70:1214–1230. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Ojalvo LS, Whittaker CA, Condeelis JS and
Pollard JW: Gene expression analysis of macrophages that facilitate
tumor invasion supports a role for wnt-signaling in mediating their
activity in primary mammary tumors. J Immunol. 184:702–712. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Quero L, Hanser E, Manigold T, Tiaden AN
and Kyburz D: TLR2 stimulation impairs anti-inflammatory activity
of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Arthritis Res Ther. 19:2452017. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Molgora M, Esaulova E, Vermi W, Hou J,
Chen Y, Luo J, Brioschi S, Bugatti M, Omodei AS, Ricci B, et al:
TREM2 modulation remodels the tumor myeloid landscape enhancing
anti-PD-1 immunotherapy. Cell. 182:886–900. e172020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Lin Y, Song Y, Zhang Y, Li X, Kan L and
Han S: New insights on anti-tumor immunity of CD8(+) T cells:
Cancer stem cells, tumor immune microenvironment and immunotherapy.
J Transl Med. 23:3412025. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Morrison BJ, Steel JC and Morris JC:
Reduction of MHC-I expression limits T-lymphocyte-mediated killing
of Cancer-initiating cells. BMC Cancer. 18:4692018. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Mirzaei R, Sarkar S, Dzikowski L, Rawji
KS, Khan L, Faissner A, Bose P and Yong VW: Brain tumor-initiating
cells export tenascin-C associated with exosomes to suppress T cell
activity. Oncoimmunology. 7:e14786472018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Gurtner K, Hessel F, Eicheler W, Dörfler
A, Zips D, Heider KH, Krause M and Baumann M: Combined treatment of
the immunoconjugate bivatuzumab mertansine and fractionated
irradiation improves local tumour control in vivo. Radiother Oncol.
102:444–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Xu L, Wang X, Zhang T, Meng X, Zhao W, Pi
C and Yang YG: Expression of a mutant CD47 protects against
phagocytosis without inducing cell death or inhibiting
angiogenesis. Cell Rep Med. 5:1014502024. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhou H, Wang W, Xu H, Liang Y, Ding J, Lv
M, Ren B, Peng H, Fu YX and Zhu M: Metabolic reprograming mediated
by tumor cell-intrinsic type I IFN signaling is required for
CD47-SIRPα blockade efficacy. Nat Commun. 15:57592024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Yang C, You J, Pan Q, Tang Y, Cai L, Huang
Y, Gu J, Wang Y, Yang X, Du Y, et al: Targeted delivery of a
PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral
Sleeping Beauty transposition shows enhanced antitumour efficacy
for advanced hepatocellular carcinoma. BMC Med. 21:3272023.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Xiao C, Li J, Wang X, Li S, Xu C, Zhang Z,
Hua A, Ding ZY, Zhang BX, Yang X and Li Z: Hydroxyethyl starch
stabilized copper-diethyldithiocarbamate nanocrystals for cancer
therapy. J Control Release. 356:288–305. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Campos B, Wan F, Farhadi M, Ernst A,
Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G,
et al: Differentiation therapy exerts antitumor effects on
stem-like glioma cells. Clin Cancer Res. 16:2715–2728. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Li S, Zhao W, An Q, Wang L, Zhu M, Ni J,
Huang X, Jiang Y, Li M, Hou J, et al: Novel cancer stem
cell-targeted retinoid ZSH-512 impedes colorectal cancer progress
via KDM3A-mediated epigenetic reprogramming. Innovation (Camb).
6:1008312025.PubMed/NCBI
|
|
130
|
Shen S, Xu X, Lin S, Zhang Y, Liu H, Zhang
C and Mo R: A nanotherapeutic strategy to overcome chemotherapeutic
resistance of cancer stem-like cells. Nat Nanotechnol. 16:104–113.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Ning ST, Lee SY, Wei MF, Peng CL, Lin SY,
Tsai MH, Lee PC, Shih YH, Lin CY, Luo TY and Shieh MJ: Targeting
colorectal cancer stem-like cells with anti-CD133
antibody-conjugated SN-38 nanoparticles. ACS Appl Mater Interfaces.
8:17793–17804. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Zhou G, Da Won Bae S, Nguyen R, Huo X, Han
S, Zhang Z, Hebbard L, Duan W, Eslam M, Liddle C, et al: An
aptamer-based drug delivery agent (CD133-apt-Dox) selectively and
effectively kills liver cancer stem-like cells. Cancer Lett.
501:124–132. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Bo Y, Zhou J, Cai K, Wang Y, Feng Y, Li W,
Jiang Y, Kuo SH, Roy J, Anorma C, et al: Leveraging intracellular
ALDH1A1 activity for selective cancer stem-like cell labeling and
targeted treatment via in vivo click reaction. Proc Natl Acad Sci
USA. 120:e23023421202023. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Tijink BM, Buter J, de Bree R, Giaccone G,
Lang MS, Staab A, Leemans CR and van Dongen GA: A phase I dose
escalation study with anti-CD44v6 bivatuzumab mertansine in
patients with incurable squamous cell carcinoma of the head and
neck or esophagus. Clin Cancer Res. 12((20 Pt 1)): 6064–6072. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Dillman RO, Nistor GI and Keirstead HS:
Autologous dendritic cells loaded with antigens from self-renewing
autologous tumor cells as patient-specific therapeutic cancer
vaccines. Hum Vaccin Immunother. 19:21984672023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Quaglino E, Conti L and Cavallo F: Breast
cancer stem cell antigens as targets for immunotherapy. Semin
Immunol. 47:1013862020. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Liao F, Zhang J, Hu Y, Najafabadi AH, Moon
JJ, Wicha MS, Kaspo B, Whitfield J, Chang AE and Li Q: Efficacy of
an ALDH peptide-based dendritic cell vaccine targeting cancer stem
cells. Cancer Immunol Immunother. 71:1959–1973. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Deng Z, Wu Y, Ma W, Zhang S and Zhang YQ:
Adoptive T-cell therapy of prostate cancer targeting the cancer
stem cell antigen EpCAM. BMC Immunol. 16:12015. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Miao L, Zhang J, Huang B, Zhang Z, Wang S,
Tang F, Teng M and Li Y: Special chimeric antigen receptor (CAR)
modifications of T cells: A review. Front Oncol. 12:8327652022.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Anlas AA and Nelson CM: Soft
microenvironments induce chemoresistance by increasing autophagy
downstream of integrin-linked kinase. Cancer Res. 80:4103–4113.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Basu S, Dong Y, Kumar R, Jeter C and Tang
DG: Slow-cycling (dormant) cancer cells in therapy resistance,
cancer relapse and metastasis. Semin Cancer Biol. 78:90–103. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Luo M, Shang L, Brooks MD, Jiagge E, Zhu
Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, et al:
Targeting breast cancer stem cell state equilibrium through
modulation of redox signaling. Cell Metab. 28:69–86.e6. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Ohta Y, Fujii M, Takahashi S, Takano A,
Nanki K, Matano M, Hanyu H, Saito M, Shimokawa M, Nishikori S, et
al: Cell-matrix interface regulates dormancy in human colon cancer
stem cells. Nature. 608:784–794. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Tang J and Yang R: All-Trans retinoic acid
induces differentiation and downregulates stemness markers and MGMT
expression in glioblastoma stem cells. Cells. 14:7462025.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Xu WW, Li B, Zhao JF, Yang JG, Li JQ, Tsao
SW, He QY and Cheung ALM: IGF2 induces CD133 expression in
esophageal cancer cells to promote cancer stemness. Cancer Lett.
425:88–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Song Y, Chen Y, Li Y, Lyu X, Cui J, Cheng
Y, Zheng T, Zhao L and Zhao G: Resveratrol suppresses
epithelial-mesenchymal transition in GBM by regulating
Smad-dependent signaling. Biomed Res Int. 2019:13219732019.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Karalis TT, Heldin P, Vynios DH, Neill T,
Buraschi S, Iozzo RV, Karamanos NK and Skandalis SS:
Tumor-suppressive functions of 4-MU on breast cancer cells of
different ER status: Regulation of hyaluronan/HAS2/CD44 and
specific matrix effectors. Matrix Biol. 78-79:118–138. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Luo X, Wang J, Chen Y, Zhou X, Shao Z, Liu
K and Shang Z: Melatonin inhibits the stemness of head and neck
squamous cell carcinoma by modulating HA synthesis via the
FOSL1/HAS3 axis. J Pineal Res. 76:e129402024. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Lang J, Zhao X, Wang X, Zhao Y, Li Y, Zhao
R, Cheng K, Li Y, Han X, Zheng X, et al: Targeted Co-delivery of
the iron chelator deferoxamine and a HIF1α inhibitor impairs
pancreatic tumor growth. ACS Nano. 13:2176–2189. 2019.PubMed/NCBI
|
|
150
|
Feng Q, Fang W, Guo Y, Hu P and Shi J:
Nebulized therapy of early orthotopic lung cancer by iron-based
nanoparticles: Macrophage-regulated ferroptosis of cancer stem
cells. J Am Chem Soc. 145:24153–24165. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Cao Y, Liu B, Cai L, Li Y, Huang Y, Zhou
Y, Sun X, Yang W and Sun T: G9a promotes immune suppression by
targeting the Fbxw7/Notch pathway in glioma stem cells. CNS
Neurosci Ther. 29:2508–2521. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Walcher L, Kistenmacher AK, Suo H, Kitte
R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S and
Kossatz-Boehlert U: Cancer Stem cells-origins and biomarkers:
Perspectives for targeted personalized therapies. Front Immunol.
11:12802020. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Probst A, Schaller T and Messmann H:
Nonhealing gastric ulcer: Progression from gastric adenoma to early
gastric cancer over 9 years. Gastrointest Endosc. 89:198–199. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li H, Yan W, Suo X, Peng H, Yang X, Li Z,
Zhang J and Liu D: Nucleus-targeted nano delivery system eradicates
cancer stem cells by combined thermotherapy and hypoxia-activated
chemotherapy. Biomaterials. 200:1–14. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Liu E, Marin D, Banerjee P, Macapinlac HA,
Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan
M, et al: Use of CAR-transduced natural killer cells in
CD19-positive lymphoid tumors. N Engl J Med. 382:545–553. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Shaim H, Shanley M, Basar R, Daher M,
Gumin J, Zamler DB, Uprety N, Wang F, Huang Y, Gabrusiewicz K, et
al: Targeting the αv integrin/TGF-β axis improves natural killer
cell function against glioblastoma stem cells. J Clin Invest.
131:e1421162021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wu Y, Ma J, Yang X, Nan F, Zhang T, Ji S,
Rao D, Feng H, Gao K, Gu X and Gao Q: Neutrophil profiling
illuminates anti-tumor antigen-presenting potency. Cell.
187:1422–1439.e24. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Ma J, Wu Y, Ma L, Yang X, Zhang T, Song G,
Li T, Gao K, Shen X, Lin J, et al: A blueprint for
tumor-infiltrating B cells across human cancers. Science.
384:eadj48572024. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ho DW, Tsui YM, Sze KM, Chan LK, Cheung
TT, Lee E, Sham PC, Tsui SK, Lee TK and Ng IO: Single-cell
transcriptomics reveals the landscape of intra-tumoral
heterogeneity and stemness-related subpopulations in liver cancer.
Cancer Lett. 459:176–185. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Fan G, Xie T, Li L, Tang L, Han X and Shi
Y: Single-cell and spatial analyses revealed the co-location of
cancer stem cells and SPP1+ macrophage in hypoxic region that
determines the poor prognosis in hepatocellular carcinoma. NPJ
Precis Oncol. 8:752024. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Malta TM, Sokolov A, Gentles AJ,
Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J,
Omberg L, Gevaert O, et al: Machine learning identifies stemness
features associated with oncogenic dedifferentiation. Cell.
173:338–354.e15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Dezem FS, Marção M, Ben-Cheikh B, Nikulina
N, Omotoso A, Burnett D, Coelho P, Hurley J, Gomez C, Phan-Everson
T, et al: A machine learning one-class logistic regression model to
predict stemness for single cell transcriptomics and spatial omics.
BMC Genomics. 24:7172023. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
He B, Gao R, Lv S, Chen A, Huang J, Wang
L, Feng Y, Feng J, Liu B, Lei J, et al: Cancer cell employs a
microenvironmental neural signal trans-activating
nucleus-mitochondria coordination to acquire stemness. Signal
Transduct Target Ther. 8:2752023. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Chen J, Xu L, Li X and Park S: Deep
learning models for cancer stem cell detection: A brief review.
Front Immunol. 14:12144252023. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Zhang J, Qi YP, Ma N, Lu F, Gong WF, Chen
B, Ma L, Zhong JH, Xiang BD and Li LQ: Overexpression of Epcam and
CD133 correlates with poor prognosis in dual-phenotype
hepatocellular carcinoma. J Cancer. 11:3400–3406. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Jia Y, Shen P, Yan T, Zhou W, Sun J and
Han X: Microfluidic tandem mechanical sorting system for enhanced
cancer stem cell isolation and ingredient screening. Adv Healthc
Mater. 10:e21009852021. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Sheinin R, Sharan R and Madi A: scNET:
Learning context-specific gene and cell embeddings by integrating
single-cell gene expression data with protein-protein interactions.
Nat Methods. 22:708–716. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Zheng H, Liu H, Li H, Dou W, Wang J, Zhang
J, Liu T, Wu Y, Liu Y and Wang X: Characterization of stem cell
landscape and identification of stemness-relevant prognostic gene
signature to aid immunotherapy in colorectal cancer. Stem Cell Res
Ther. 13:2442022. View Article : Google Scholar : PubMed/NCBI
|
